I have been mentioning ARNI on this page for a while. I even mentioned it yesterday and today and yesterday it was up about 13 cents both days. This was a $.30 cent stock not long ago. Next time you'll listen to me. ARNI is in stage two of development for cancer drugs
I like a $.44 cent stock that's owned by Soros, Phillip Frost, Opko Health and have a drug in phase 2. Also Arie S. Belldegrun, MD is the chairman of ARNI and he's the CEO of Kite Pharma also. He also sold some of his other bio pharma companies. Again I do like AEMD, but ARNI has less risk being that's its owned by Soros, Phillip Frost, Opko Health and Arie S. Belldegrun and its so inexpensive with two drugs in phase 2
they need press from the WSJ, Barrons, Forbes, Fortune, NY Times, CNBC, Fox Business not from PennyStocksWeekly
Afrezza will be out of business by 2020
so they are admitting they won't be able to complete in the diabetes market where all the other bands advertise.
all these dumb fools were saying that Sanofi would start a major advertising campaign for Afrezza. I said Sanofi wanted nothing do do with Afrezza because they had their own diabetes products and would drive MNKD out of business. So Sanofi almost accomplished their goals of putting mnkd out of business and now mnkd is helping Sanofi by doing nothing while Toujeo, a sanofi product was being advertised from the day it got FDA approved. You guys are a bunch of idiots, watching mnkd go from $4 to $1
if you want mnkd to go out of business they are headed that way with no advertising for Afrezza.
why didn't mnkd consider suing Sanofi for not living up to their agreement to market Afrezza?
i'll leave my money where George Soros, Arie Belldegrun, M.D., FACS, Dr. Frost, OPKO Health etc put their money.
MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 105.71 million shares. The previous reading was 103.74 million. Shares closed most recently at $0.95, in a 52-week trading range of $0.64 to $7.32.